Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Danaher Corporation (NYSE:DHR). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in Danaher stock on August 31st. The trade occurred in the Representative’s “HERN FAMILY FOUNDATION” account.
Representative Kevin Hern also recently made the following trade(s):
- Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
- Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
- Sold $15,001 – $50,000 in shares of STERIS (NYSE:STE) on 9/15/2026.
- Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
- Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
- Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of IQVIA (NYSE:IQV) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
- Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
- Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.
Danaher Stock Performance
NYSE DHR traded down $1.21 on Tuesday, reaching $226.12. The stock had a trading volume of 3,598,319 shares, compared to its average volume of 4,468,455. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a fifty day moving average of $206.57 and a two-hundred day moving average of $192.90. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market cap of $158.96 billion, a P/E ratio of 40.16, a price-to-earnings-growth ratio of 2.80 and a beta of 0.78.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s payout ratio is currently 28.42%.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the stock. Royal Bank Of Canada upped their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Finally, Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research note on Monday, July 6th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $230.23.
Check Out Our Latest Research Report on Danaher
Institutional Trading of Danaher
A number of institutional investors have recently bought and sold shares of DHR. First Command Advisory Services Inc. grew its holdings in shares of Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after acquiring an additional 47 shares in the last quarter. Studio Investment Management LLC boosted its holdings in shares of Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after acquiring an additional 51 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares in the last quarter. JDH Wealth Management LLC increased its position in shares of Danaher by 4.5% in the first quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after purchasing an additional 55 shares during the period. Finally, OneAscent Financial Services LLC raised its stake in Danaher by 5.5% in the fourth quarter. OneAscent Financial Services LLC now owns 1,069 shares of the conglomerate’s stock valued at $245,000 after purchasing an additional 56 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
About Representative Hern
Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.
Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.
Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
Featured Articles
- Five stocks we like better than Danaher
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
